Breaking News Instant updates and real-time market news.

PRTA

Prothena

$12.78

-0.13 (-1.01%)

16:24
11/06/18
11/06
16:24
11/06/18
16:24

Prothena reports Q3 EPS (62c), consensus (98c)

Reports Q3 revenue $255K, may not compare to consensus $800K. "We continue to focus on advancing our neuroscience pipeline of investigational therapeutics for a number of diseases, and continue to make progress across our proprietary programs as well as our collaboration programs with Roche and Celgene," said Gene Kinney, PhD, President and Chief Executive Officer of Prothena. "We are encouraged that other therapeutics for ATTR amyloidosis have demonstrated benefit to patients by impacting the biological pathway leading to the formation of amyloid deposits, and we look forward to analyzing data from our PRX004 program which we expect will offer insights on a mechanism targeting the misfolded, pathogenic form of the TTR protein. Our Phase 1 study of PRX004 and the Phase 2 PASADENA study of prasinezumab (PRX002/RG7935) remain on track for initial data in 2019 and 2020, respectively."

PRTA Prothena
$12.78

-0.13 (-1.01%)

04/24/18
BTIG
04/24/18
DOWNGRADE
BTIG
Neutral
Prothena downgraded to Neutral from Buy at BTIG
BTIG analyst Robert Hazlett downgraded Prothena to Neutral from Buy after the PRONTO study read out negatively, which led directly to the discontinuation of the entire NEOD001 program. Despite noting that the company has programs "that appear quite promising," Hazlett prefers to move to the sidelines with important catalysts now farther out, with a readout for its 002 program in Parkinson's due in 2020.
04/24/18
04/24/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alcoa (AA) downgraded to Neutral from Buy at Citi with analyst Alexander Hacking saying the stock is up 60% year-over-year. 2. Dynagas LNG (DLNG) downgraded to Underperform from Market Perform at Wells Fargo with analyst Michael Webber saying another distribution cut is possible given expensive dropdowns from the company's private sponsor. 3. Skyworks (SWKS) downgraded to Neutral from Buy at Mizuho with analyst Vijay Rakesh saying the effects of a maturing handset cycle could start to impact the RF suppliers. 4. Prothena (PRTA) downgraded to Neutral from Buy at BTIG and to Perform from Outperform at Oppenheimer. 5. Donegal Group (DGICA) downgraded to Neutral from Outperform at Boenning & Scattergood. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/21/18
LEHM
05/21/18
DOWNGRADE
Target $12
LEHM
Underweight
Prothena downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Geoffrey Meacham downgraded Prothena to Underweight and cut his price target for the shares to $12 from $14. The analyst sees limited value creating pipeline events in the near-term after the company discontinued development of NEOD001, an investigational antibody that was being evaluated for the treatment of AL amyloidosis. He believes it remains too early to assign much value to PRX002 in Parkinson's or PRX004 in ATTR amyloidosis.
06/15/18
CANT
06/15/18
NO CHANGE
Target $18
CANT
Overweight
Prothena price target raised to $18 from $14 at Cantor Fitzgerald
Cantor Fitzgerald analyst William Tanner raised his price target for Prothena to $18 citing his analysis of the potential value of the company's drug discovery platform and management's recently announced restructuring plan. The analyst reiterates a Overweight rating on the shares.

TODAY'S FREE FLY STORIES

14:50
02/20/19
02/20
14:50
02/20/19
14:50
General news
Treasury Action: there wasn't any strong reaction to the FOMC minutes »

Treasury Action: there…

SSNLF

Samsung

$0.00

(0.00%)

14:49
02/20/19
02/20
14:49
02/20/19
14:49
Hot Stocks
Samsung introduces new line of Galaxy S10 phones »

Samsung inroduced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIPS

Vipshop

$7.28

0.33 (4.75%)

14:49
02/20/19
02/20
14:49
02/20/19
14:49
Options
Vipshop options imply 15.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SSNLF

Samsung

$0.00

(0.00%)

, TMUS

T-Mobile

$72.78

0.27 (0.37%)

14:47
02/20/19
02/20
14:47
02/20/19
14:47
Hot Stocks
Samsung unveils Galaxy Fold »

Samsung Electronics…

SSNLF

Samsung

$0.00

(0.00%)

TMUS

T-Mobile

$72.78

0.27 (0.37%)

T

AT&T

$30.87

0.24 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

  • 20

    Mar

VRTU

Virtusa

$50.50

-0.61 (-1.19%)

14:46
02/20/19
02/20
14:46
02/20/19
14:46
Conference/Events
Virtusa management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 01

    Mar

  • 04

    Mar

  • 05

    Mar

  • 19

    Mar

ADI

Analog Devices

$106.55

2.34 (2.25%)

14:46
02/20/19
02/20
14:46
02/20/19
14:46
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 13

    Mar

  • 09

    Apr

  • 28

    May

SSNLF

Samsung

$0.00

(0.00%)

14:44
02/20/19
02/20
14:44
02/20/19
14:44
Hot Stocks
Samsung unveils Galaxy Watch Active, Galaxy Fit, and Galaxy Buds »

Samsung Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAK

Northern Dynasty

$0.89

0.0029 (0.33%)

14:44
02/20/19
02/20
14:44
02/20/19
14:44
Hot Stocks
Northern Dynasty says Pebble Project Draft Environmental Impact Statement posted »

Northern Dynasty Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSCO

Tractor Supply

$97.56

0.53 (0.55%)

14:42
02/20/19
02/20
14:42
02/20/19
14:42
Conference/Events
Tractor Supply management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 06

    Mar

PWR

Quanta Services

$36.49

0.815 (2.28%)

14:40
02/20/19
02/20
14:40
02/20/19
14:40
Options
Repeat put buyers in Quanta Services ahead of earnings »

Repeat put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EADSY

Airbus

$0.00

(0.00%)

14:38
02/20/19
02/20
14:38
02/20/19
14:38
Conference/Events
Airbus management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

NTR

Nutrien

$54.57

1.22 (2.29%)

14:35
02/20/19
02/20
14:35
02/20/19
14:35
Options
Nutrien put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 27

    Feb

14:35
02/20/19
02/20
14:35
02/20/19
14:35
General news
On the balance sheet: »

On the balance sheet: the…

SSNLF

Samsung

$0.00

(0.00%)

, VZ

Verizon

$55.67

0.24 (0.43%)

14:34
02/20/19
02/20
14:34
02/20/19
14:34
Periodicals
Samsung unveils Galaxy S10 5G, Verge reports »

Samsung (SSNLF) intends…

SSNLF

Samsung

$0.00

(0.00%)

VZ

Verizon

$55.67

0.24 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

  • 03

    Mar

  • 11

    Mar

  • 11

    Mar

FDP

Fresh Del Monte

$29.80

0.53 (1.81%)

14:34
02/20/19
02/20
14:34
02/20/19
14:34
Hot Stocks
Breaking Hot Stocks news story on Fresh Del Monte »

Fresh Del Monte trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTK

Cytokinetics

$7.52

-0.17 (-2.21%)

, AMGN

Amgen

$187.14

0.17 (0.09%)

14:27
02/20/19
02/20
14:27
02/20/19
14:27
Recommendations
Cytokinetics, Amgen analyst commentary  »

Piper reiterates…

CYTK

Cytokinetics

$7.52

-0.17 (-2.21%)

AMGN

Amgen

$187.14

0.17 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 28

    Feb

  • 01

    Mar

GG

Goldcorp

$11.52

0.25 (2.22%)

14:25
02/20/19
02/20
14:25
02/20/19
14:25
Options
Goldcorp call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
02/20/19
02/20
14:25
02/20/19
14:25
General news
FX Action: The Dollar »

FX Action: The Dollar…

SSNLF

Samsung

$0.00

(0.00%)

, AAPL

Apple

$172.67

1.72 (1.01%)

14:23
02/20/19
02/20
14:23
02/20/19
14:23
Periodicals
Samsung unveils new foldable phone called Galaxy Fold, Verge reports »

At Samsung's Galaxy…

SSNLF

Samsung

$0.00

(0.00%)

AAPL

Apple

$172.67

1.72 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 01

    Mar

FDP

Fresh Del Monte

$29.80

0.53 (1.81%)

14:20
02/20/19
02/20
14:20
02/20/19
14:20
Hot Stocks
Fresh Del Monte board suspends quarterly cash dividend »

Fresh Del Monte Produce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:20
02/20/19
02/20
14:20
02/20/19
14:20
General news
FOMC minutes to Januayr 29, 30 meeting: »

FOMC minutes to Januayr…

NXTM

NxStage Medical

$29.99

0.35 (1.18%)

, FMS

Fresenius Medical

$40.17

1.79 (4.66%)

14:18
02/20/19
02/20
14:18
02/20/19
14:18
Hot Stocks
FTC requires NxStage, Fresenius Medical to divest bloodline tubing assets »

The Federal Trade…

NXTM

NxStage Medical

$29.99

0.35 (1.18%)

FMS

Fresenius Medical

$40.17

1.79 (4.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 05

    Mar

  • 12

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
02/20/19
02/20
14:17
02/20/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
02/20/19
02/20
14:16
02/20/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$54.65

-0.65 (-1.18%)

14:15
02/20/19
02/20
14:15
02/20/19
14:15
Options
Etsy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.